LeonaBio, Inc. (LONA)

LeonaBio Statistics

Total Valuation

LeonaBio has a market cap or net worth of $83.04 million. The enterprise value is -$6.56 million.

Market Cap	83.04M
Enterprise Value	-6.56M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

LeonaBio has 9.39 million shares outstanding. The number of shares has increased by 11.12% in one year.

Current Share Class	9.39M
Shares Outstanding	9.39M
Shares Change (YoY)	+11.12%
Shares Change (QoQ)	+35.53%
Owned by Insiders (%)	5.67%
Owned by Institutions (%)	41.73%
Float	6.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.90
P/TBV Ratio	2.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.03.

Current Ratio	1.88
Quick Ratio	1.86
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -290.81% and return on invested capital (ROIC) is -57.23%.

Return on Equity (ROE)	-290.81%
Return on Assets (ROA)	-28.31%
Return on Invested Capital (ROIC)	-57.23%
Return on Capital Employed (ROCE)	-76.55%
Weighted Average Cost of Capital (WACC)	16.34%
Revenue Per Employee	n/a
Profits Per Employee	-$5.56M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +220.45% in the last 52 weeks. The beta is 2.23, so LeonaBio's price volatility has been higher than the market average.

Beta (5Y)	2.23
52-Week Price Change	+220.45%
50-Day Moving Average	7.90
200-Day Moving Average	5.40
Relative Strength Index (RSI)	47.10
Average Volume (20 Days)	47,107

Short Selling Information

The latest short interest is 100,206, so 1.07% of the outstanding shares have been sold short.

Short Interest	100,206
Short Previous Month	44,014
Short % of Shares Out	1.07%
Short % of Float	1.56%
Short Ratio (days to cover)	1.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-34.18M
Pretax Income	-105.61M
Net Income	-105.61M
EBITDA	-33.21M
EBIT	-34.18M
Earnings Per Share (EPS)	-$24.70

Balance Sheet

The company has $88.33 million in cash and $803,000 in debt, with a net cash position of $87.53 million or $9.32 per share.

Cash & Cash Equivalents	88.33M
Total Debt	803,000
Net Cash	87.53M
Net Cash Per Share	$9.32
Equity (Book Value)	27.79M
Book Value Per Share	2.98
Working Capital	41.96M

Cash Flow

Operating Cash Flow	-45.73M
Capital Expenditures	n/a
Depreciation & Amortization	972,000
Net Borrowing	n/a
Free Cash Flow	-45.73M
FCF Per Share	-$4.87

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LeonaBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.12%
Shareholder Yield	-11.12%
Earnings Yield	-130.43%
FCF Yield	-56.48%

Analyst Forecast

The average price target for LeonaBio is $10.00, which is 13.12% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	13.12%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 18, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Sep 18, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1